Rameda Pharmaceuticals Email Format

Pharmaceutical ManufacturingGiza, Egypt1001-5000 Employees

Rameda Pharmaceuticals is a pharmaceutical manufacturing company headquartered in Giza, Egypt, with an employee base of 1,001 to 5,000 people. Founded in 1994 by Gulf investors, the company entered a licensing agreement with Alcon in 1999 to manufacture ophthalmology products and later renewed syrup production to achieve GMP standards. In 2011, Compass Capital led a consortium to acquire the company, with a plan to establish Rameda as a regional leader, and M+W Group was commissioned to transform solid dosage and beta-lactam areas to GMP compliance. In 2024, Rameda expanded its offices to Kuwait and broader Asia and pursued partnerships to expand exports to East Asia, Africa, and the Arabian Gulf. The company went public on the Egyptian Exchange in December 2019, and in 2022 the International Finance Corporation partnered with Rameda to finance green solutions at its Cairo manufacturing facilities.

Sign up for free to view info

Company overview Employee directory